These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Recent developments in the biology of respiratory syncytial virus: are vaccines and new treatments just round the corner? Hussell T; Openshaw P Curr Opin Microbiol; 1999 Aug; 2(4):410-4. PubMed ID: 10458984 [TBL] [Abstract][Full Text] [Related]
3. Do recombinant-engineered nanoparticle vaccines hold promise for the prevention of respiratory syncytial virus? Lee YT; Kwon YM; Kang SM Nanomedicine (Lond); 2016; 11(5):439-42. PubMed ID: 26893211 [No Abstract] [Full Text] [Related]
12. Seasonal variation of maternally derived respiratory syncytial virus antibodies and association with infant hospitalizations for respiratory syncytial virus. Stensballe LG; Ravn H; Kristensen K; Meakins T; Aaby P; Simoes EA J Pediatr; 2009 Feb; 154(2):296-8. PubMed ID: 19150677 [TBL] [Abstract][Full Text] [Related]
13. The role of immunoprophylaxis in the reduction of disease attributable to respiratory syncytial virus. Meissner HC; Bocchini JA; Brady MT; Hall CB; Kimberlin DW; Pickering LK Pediatrics; 2009 Dec; 124(6):1676-9. PubMed ID: 19948632 [No Abstract] [Full Text] [Related]
15. Subgroups A and B respiratory syncytial virus isolated in Ehime Prefecture, 1995-1999. Kondo R; Yoshida K; Yamashita Y; Oseto M; Asai T; Inouye H; Nakano S; Ishimaru Y Jpn J Infect Dis; 2001 Aug; 54(4):155-6. PubMed ID: 11684787 [No Abstract] [Full Text] [Related]
16. Respiratory syncytial virus: babies and antibodies. Hemming VG; Prince GA Infect Agents Dis; 1992 Feb; 1(1):24-32. PubMed ID: 1365525 [No Abstract] [Full Text] [Related]
17. [The evaluation by indirect immunofluorescence of the incidence of respiratory syncytial virus in acute respiratory disorders in infants]. Berinde MA; Herzog G Bacteriol Virusol Parazitol Epidemiol; 1998; 43(1-2):65-8. PubMed ID: 9718753 [No Abstract] [Full Text] [Related]
18. Persistence of proinflammatory response after severe respiratory syncytial virus disease in children. Bermejo-Martin JF; Garcia-Arevalo MC; Alonso A; De Lejarazu RO; Pino M; Resino S; Tenorio A; Bernardo D; Leon AJ; Garrote JA; Ardura J; Dominguez-Gil M; Eiros JM; Blanco-Quiros A; Munoz-Fernandez MA; Kelvin DJ; Arranz E J Allergy Clin Immunol; 2007 Jun; 119(6):1547-50. PubMed ID: 17451801 [No Abstract] [Full Text] [Related]
19. Vaccines for neonatal viral infections: towards a live respiratory syncytial virus vaccine:a study in risk. McIntosh ED; Malinoski FJ; Randolph VB Expert Rev Vaccines; 2004 Aug; 3(4):353-7. PubMed ID: 15270633 [TBL] [Abstract][Full Text] [Related]
20. To palivizumab or not to palivizumab - that is the question. Paton J Paediatr Respir Rev; 2013 Jun; 14(2):126-7. PubMed ID: 23414959 [No Abstract] [Full Text] [Related] [Next] [New Search]